article thumbnail

The 2023-2024 Flu Season: What Pharmacists Need to Know

Digital Pharmacist

As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. The most effective preventive measure against the flu is getting an annual flu vaccine. According to the CDC, in the 2023-2024 season, the U.S.

article thumbnail

Highlights from ESCMID Global 2024: AI, climate change and AMR

Hospital Pharmacy Europe

With hundreds of invited speakers, the ESCMID Global 2024 gathering in Barcelona, Spain (27-30 April), welcomed approximately 16,000 delegates for five days of knowledge exchange, collaboration and innovation. The post Highlights from ESCMID Global 2024: AI, climate change and AMR appeared first on Hospital Pharmacy Europe.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CDC Director Mandy Cohen unscathed in her first congressional testimony

STAT

They hope to gut a data program and slash HIV funds in the 2024 budget, but they also asked questions about the breadth of the agency’s portfolio outside of communicable diseases. Read the rest…

article thumbnail

CureVac gets an early date in Covid-19 vaccine patent case with Pfizer/BioNTech

Pharmaceutical Technology

The ongoing patent litigation between CureVac and Pfizer /BioNTech will move to a court in Virginia following a request from Curevac, potentially bringing forward the trial date to sometime in 2024. The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly.

Vaccines 116
article thumbnail

COVID-19, Flu, and RSV in 2023: What Pharmacists Should Know

Digital Pharmacist

In this blog, we will explore what pharmacies should know about the recent surge in COVID-19, the co-occurrence of Flu and RSV, and the significance of vaccinations and testing in controlling these infections. Vaccinating For Respiratory Viruses in 2023 Vaccination remains the most potent tool in combating severe illness from these viruses.

article thumbnail

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.

article thumbnail

Novavax is on thin ice, and the latest update isn’t exactly encouraging

STAT

On 2024 guidance, Merck said it expects sales in the range of $62.7-$64.2 In 2024, as in 2023, the industry’s fate seems inextricable from interest rates. Novavax won’t disclose its revenue until later this month, but its latest communications don’t exactly inspire confidence.